NDC 49502-475 – Symfi
Efavirenz 600 mg/1; Lamivudine 300 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral
Product NDC49502-475
Product details
- Brand name
- Symfi
- Generic name
- Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
- Labeler
- Viatris Specialty LLC
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA022142
- Marketed since
- April 25, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Efavirenz 600 mg/1
- Lamivudine 300 mg/1
- Tenofovir Disoproxil Fumarate 300 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 49502-475-93 | 1 BOTTLE, PLASTIC in 1 CARTON (49502-475-93) / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC | Apr 25, 2018 |